immunotherapy

16 April 2025

Julián Pardo Jimeno: “It is essential to collaborate with the right professionals and work in multidisciplinary teams.”

In this interview, the IIS Aragón researcher talks about his work leading the 'Immunotherapy, Inflammation, Infection and Cancer (I3C)' group (GIIS055) and the main challenges they face.
6 February, 2025

A project brings cancer researchers into the classroom

The fifth edition of 'Get to Know Them' by the Spanish Association for Cancer Research (ASEICA) "puts 350 female cancer researchers on the map", ten of them from the IIS Aragón, to reach schools and universities throughout Spain.
September 18, 2024

Luis Alberto Anel Bernal: “A research career, and especially in this field, is a long-distance race that not everyone is suited to”

In this interview, the IIS Aragón researcher talks about his work leading the 'Apoptosis, Immunity and Cancer' Group (GIIS090) and his research interests.
19 March, 2024

Alberto Jiménez Schuhmacher presents in Barbastro the topic “The immune system, the police of the body”

Alberto Jiménez Schuhmacher, head of the Molecular Oncology Group of the Aragon Health Research Institute (IIS Aragón) and ARAID researcher, will give a conference this Wednesday at the UNED in Barbastro, at 19:00 p.m.
13 March, 2024

The effectiveness of immunotherapy reaches 70% in some types of cancer

The V International Symposium on Cancer Onco-Immunology and Immunotherapy, organized by the IIS Aragón, had more than 200 attendees under the scientific direction of Antonio Antón and Alberto Anel, professors at the University of Zaragoza, and researchers at the IIS Aragón.